News from the Foundation
North Bethesda, MD – February 10, 2024—The Foundation for the National Institutes of Health (FNIH) today announced the launch of a new public-private partnership to develop tools to identify pregnant women at high risk of early-onset pree...
The Preeclampsia Foundation welcomed a new group of officers to their 2024 Board of Directors. Robyn D’Oria, MA, RNC, APN will serve as the new Board chair.
The Preeclampsia Foundation announced today that the Centers for Disease Control and Prevention (CDC) awarded new funding for its MoMMA’s Voices program, a national coalition of patient advocacy organizations and individuals with "lived experience" –...
Abt Associates, together with subcontractors HealthBegins and the MoMMA’s Voices program of the Preeclampsia Foundation, will provide technical assistance and evaluation support to 36 HRSA-supported health centers who are implementing innovative appr...
Recommendations for high-risk expecting parents and health care providers to promote the prevention of preeclampsia, a leading cause of pregnancy-related death in the United States.
While on the road this summer for the Reconnect Tour 2022, I met with academic and clinical centers of preeclampsia excellence whose leadership recognize that there is a gap between our pregnancy care and everything that happens beyond pregnancy.
Education Manager Maggie Barker recaps the 2022 Alliance for Innovation in Maternal Health Conference.
The Preeclampsia Foundation and the Preeclampsia Foundation Canada have announced that John Snelgrove, MD, MSc, and Samantha Wilson, PhD, are their 2022 Vision Grant research award recipients respectively.
CEO Eleni Z. Tsigas reflects on preeclampsia's impact on dads and how we can improve our support to empower them as partners in mom's health.
Investigators meeting the research funding program’s criteria are invited to submit Letters of Intent for 2022 proposals by August 22, 2022.
1665494821.png)
CEO Eleni Tsigas shares the first half of her ReConnect preeclampsia roadtrip, while asking the question: is innovation enough?
New research shows many patients not routinely educated about preeclampsia signs and symptoms during their pregnancy journey.